Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Biochim Biophys Acta. 2011 Nov 29;1825(2):140–152. doi: 10.1016/j.bbcan.2011.11.003

Figure 1. Prostate cancer's progression and treatment.

Figure 1

Prostate cancer patients with high risk are recommended to have surgery, radiation, and/or hormone therapies. Although these treatments are efficient in general, some patients have recurrent diseases, at which stage current treatment options, mostly chemotherapy, are limited in terms of clinical outcome. It is hoped that development in targeted therapies can provide more options for the recurrent and metastatic prostate cancers.